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Vaccines with synthetic peptides induce the immune response to epitopes that bind to several HLA alleles.
By using a TEPITOPE algorithm, we selected and analyzed the T-cell responses of peripheral blood mono-
nuclear cells from 29 paracoccidioidomycosis (PCM) patients to peptides of the immunodominant gp43
antigen of Paracoccidioides brasiliensis, the causative agent of PCM.
Paracoccidioidomycosis (PCM) is caused by the fungus
Paracoccidioides brasiliensis and is the prevalent human sys-
temic mycosis in Latin America (4, 14, 19, 20). Current che-
motherapy for the treatment of PCM is usually successful,
although the treatment regimens are very long and relapses are
frequent. Patients with chronic PCM would greatly benefit
from a specific and active immunotherapy that could shorten
the treatment period, increase the efficiency of chemotherapy,
and protect against the relapse of disease.
The immunodominant 43-kDa glycoprotein 43 (gp43) is the
major diagnostic antigen for P. brasiliensis infection (17, 18; re-
viewed in reference 23) because it is recognized in virtually all
sera from infected patients with active PCM, using different se-
rological methods (6, 21). Although gp43 may be a virulence
factor under some experimental conditions involving cell adhe-
sion (9, 24) and PCM patients have blood circulating gp43 (12,
16), this antigen elicits a protective cellular immune response in
mice of different haplotypes. Epitope mapping of the entire gp43
protein in the murine model identified the 15-mer peptide at
positions 181 to 195, named P10, as the carrier of the immuno-
dominant epitope in lymphocyte proliferation assays. The immu-
nization of mice with either purified gp43 or P10 peptide was
protective against subsequent intratracheal challenge with viru-
lent P. brasiliensis agents (22), and use of P10 as an adjuvant to
chemotherapy shortened the period of treatment and protected
against relapsing disease (13). Additionally, previous data from
our group identified, with the aid of the TEPITOPE algorithm
that predicts binding to 25 different HLA-DR molecules (2, 3),
the P10-analogous peptide gp43 at sequence positions 180 to 194
[gp43(180–194)] as the immunodominant peptide recognized by
up to 53% of the peripheral blood mononuclear cells (PBMC)
from 19 treated PCM patients (10). In this work, we extended the
data previously reported by testing the previously selected pep-
tides with PBMC from 10 additional PCM patients and 13 healthy
donor individuals to evaluate specificity. All PCM patients were
typed for HLA class II (Fig. 1, HLA distribution), and the obser-
vation that a great diversity of HLA-DR molecules is associated
with the recognition of each peptide (Table 1) confirms the ab-
sence of a correlation of the disease with the HLA molecule (7),
suggesting that peptides predicted to bind promiscuously were
able to be presented by multiple HLA-DR molecules. Addition-
ally, the frequency of allelic variation in the distribution of the
HLA-DRs of the tested patients is similar to that of the Brazilian
population spectra, so that the lack of some haplotypes (Fig. 1)
reflects the low frequency of these haplotypes in the Brazilian
population (8). The proliferative response of PBMC from 29
different PCM patients (Table 1) showed that 76% (22/29) re-
sponded to at least one peptide and that the ideal peptide con-
centration for recognition varied among individuals and peptides
tested. Peptide gp43(181–195) was the most promiscuous peptide,
recognized by 48% (14/29) of the PCM patients tested, followed
by gp43(180–194), gp4(179–199), gp43(95–109), gp43(183–197),
gp43(45–59), gp43(106–120), and gp43(283–298), which were
recognized by 45%, 45%, 41%, 40%, 39%, 33%, and 27% of
patients, respectively (Table 1). The pooling effect of peptides
gp43(45–59), gp43(94–108), gp43(106–120), gp43(283–298), and
gp43(181–195) showed that six out of seven (86%) individuals
tested recognized the pool of the five selected peptides, increasing
the frequency of recognition compared to that of peptides tested
individually (Table 1). The proliferative responses of 13 healthy
individuals against the eight peptides selected by TEPITOPE
analysis showed that 7 individuals recognized the gp43 protein but
with lower stimulation index (SI) values (2.0 to 4.4) than those of
the PCM patients. Moreover, two individuals recognized three
different peptides from the P. brasiliensis gp43 protein with simi-
larly low SI (2.0 to 2.4) responses (Table 2). The fact that PBMC
from some healthy individuals with typical urban lives, and there-
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fore not exposed to P. brasiliensis, recognized gp43 and some of its
derived peptides suggests that these individuals may have been
fortuitously exposed to P. brasiliensis on a trip to reserve areas of
the fungus or that they have developed a cross-recognition re-
sponse to other related fungal antigens. Previous data have shown
that upon cloning and sequencing of the whole gp43 sequence,
gp43 presents 54 to 60% sequence homology with the N- and
C-terminal domains of exo--1,3-D-glucanases from Saccharomy-
ces cerevisiae and Candida albicans (5). Using the Internet-avail-
able FASTS tool (11) to search for the exo--1,3-D-glucanase
region from several different microorganisms presenting se-
quence homology to these recognized peptides, we identified se-
quence positions 181 to 201 of the exo--1,3-D-glucanase region
from Blumeria graminis {GenBank accession number Q96V64;
VPNTLRAIQALAERYAPQTDV [named herein bg(181–201)]}
and sequence positions 251 to 265 from the glucanase-like protein
of Aspergillus nidulans {a hypothetical protein within the endo-
glucanase region; GenBank accession number XP661656; EQTI
LAFETLAQRYL [named herein as(251–265)]}, which present
sequence homology with gp43(179–199) and also contain the
gp43(181–195) peptide. In the same way, we also identified that
the position sequence 122 to 137 of the exo--1,3-D-glucanase
region from Saccharomyces castelli {GenBank accession number
Q875Z0; IDDHVKVACSWGTGVL [named herein sc(122–
137)]} has sequence homology with the P. brasiliensis gp43(283–
298) peptide (data not shown). Moreover, TEPITOPE analysis
showed that these peptides from different fungi could be pre-
sented by several HLA-DR molecules (data not shown), among
which were those HLA-DR molecules carried by healthy individ-
uals whose T lymphocytes recognized the peptides, strongly sup-
porting the results obtained. These data suggest that these indi-
viduals may have had previous contact with fungi carrying the
related exo--1,3-D-glucanases as important enzymes responsible
for the synthesis of the fungal cell wall. The antigen may have
been released by cell lysis and peptide bg(181–201), as(350-370),
or sc(122–137) or functionally similar peptides from other fungi
with similar antigenic -glucanases, presented by antigen-present-
ing cells to T lymphocytes.
Recent data from several groups have suggested that vaccines
based on a unique epitope are not potent enough to induce a
complete protective immune response. The combination of mul-
tiple B- and/or T-cell epitopes in a pool or as a polypeptide with
multiple epitopes showed an increase in immunogenicity (1, 15).
FIG. 1. HLA-DR distribution of the 29 PCM patients examined.
TABLE 1. Proliferation responses of PBMC from 29 PCM patients to the gp43 and eight gp43 peptides selected by a TEPITOPE algorithma
Patient
ID
no.b
SI value for indicated concn (M) of peptide: SI for control
gp43
(45–59)
gp43
(94–108)
gp43
(106–120)
gp43
(283–295)
gp43
(180-194)
gp43
(183–197)
gp43
(179–199)
gp43
(181–195)
Peptide
pool gp43
(1 g) PHA
0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10
02* 3.2 17.5 14.9 - 2.6 2.7 4.5 3.9 4.5 3.0 2.5 8.4 5.0 12.0 8.1 18.5 19.5 4.4 32.6 8.3 7.8 22.2 7.3 5.5 210.6 2,368.6
03* - - - 2.8 5.2 3.9 2.0 2.1 - 2.8 8.3 2.9 3.2 5.3 4.3 5.1 4.1 15.7 2.4 - - 5.2 7.8 5.5 26.9 16.9
18* 5.7 3.8 - 3.4 4.6 - 2.9 2.3 - 3.3 2.9 - 3.1 9.2 - 7.1 4.5 2.3 2.1 - - 8.8 3.4 - 5.0 243.0
09* 2.0 - - - 2.1 - 2.0 - - - 2.1 3.0 2.6 3.5 2.2 2.0 2.5 - 4.1 2.2 - - - 2.7 40.8 1,181.7
04 - 2.3 5.0 - - - 2.3 - - - - - 3.6 2.0 - - - 2.5 - - 2.2 2.1 - 2.3 19.1 946.5
21 2.8 - - 2.1 5.3 - - - 2.3 5.2 - - 15.8 - - - 4.8 - 3.1 4.5 - 2.3 - 4.1 41.5 418.9
28 2.0 - - - 2.0 - - 2.0 - - - 2.1 - - - - - - - - - - - - 8.4 358.6
08* - - 6.8 - 2.4 2.6 - - - - - - - 2.3 3.5 - - - - - - - - 4.2 25.6 121.6
07 - - - 3.9 2.6 - - 2.1 - - - - 2.1 4.5 2.5 - - 2.6 - 3.1 3.0 - 5.2 4.0 20.7 169.0
13* - - - 3.9 - - 12.0 2.6 - - - - - 3.4 - - 6.2 - - - - - - - 19.4 761.3
14* 4.2 4.5 - - - - - - - - - - 10.6 4.5 - - 2.8 - 3.4 7.8 - 2.6 6.1 - 88.3 710.7
06* 2.0 - - - - - - - - - - - - 2.8 - - - - - 2.2 - - 7.7 - 29.8 803.8
11* - - - - - 2.0 - - - - - - - 2.3 6.8 - 7.7 - - - 10.2 - - 5.2 30.6 977.9
13* - - - - 2.2 - - - 2.3 - - - - 3.4 - - 6.2 - - - - - - - 29.8 340.1
26 - - - - 2.2 - - - - - - - - - - - - - - - - 3.8 - - 2.9 - - 40.5 205.4
25 2.3 3.7 3.2 - - - - - - - - - - - - - - - - - - - - - 2.6 7.1 - 15.2 188.9
22 - - - 2.6 2.3 2.0 - - - - - - - - - - - - - - - - - - 3.4 - - 8.8 149.6
15* - - 3.4 - - - - - - - - - - - - - - - - - - - - - 8.8 2,205.8
17* - - - - - - - - - - 2.2 5.4 - - - - - - 2.5 - - - - - 23.4 293.1
01* - - - - - - - - - - - - - - 2.6 - - - - 2.2 - 2.8 7.8 - 11.6 261.6
20* - - - - - - - - - - - 2.1 - - - - - - - - - - - - 3.8 236.7
23 - - - - - - - - - - - - - - - - - 2.0 - - - - 3.7 - 3.6 4.9 2.0 26.6 172.4
16* - - - - - - - - - - - - - - - - - - - - - - - - 18.1 740.0
10* - - - - - - - - - - - - - - - - - - - - - - - - 15.0 162.4
12* - - - - - - - - - - - - - - - - - - - - - - - - - 2.4 - 19.9 261.4
05* - - - - - - - - - - - - - - - - - - - - - - - - 3.2 53.4
19* - - - - - - - - - - - - - - - - - - - - - - - - 2.3 106.5
29 - - - - - - - - - - - - - - - - - - - 2.2 - - - - 7.2 151.2
24 - - - - - - - - - - - - - - - - - - - - - - - - - 7.2 - 76.9 248.4
a PBMC (105 cells/well) were stimulated by peptides at concentrations of 0.1, 1.0, and 10.0 M as described. Only positive stimulation index (SI) values of 2 are
shown. Dashes (-) correspond to SI values of 2. Positive control, phytohemagglutinin (PHA). Blank cells, not done.
b *, data previously shown in the study by Iwai et al. (10), except for peptides gp43(183–197), gp43(179–199), and gp43(181–195). ID, identification.
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In this work, we also observed an increase in the recognition from
48% to 86% of patients when we used the combination of five
promiscuous peptides selected by TEPITOPE analysis. The pep-
tide combination approach opens the possibility for a successful
therapeutic peptide-based vaccine that would work as an adjuvant
to the currently used fungal chemotherapy, thereby improving its
efficacy and reducing the time of the treatment.
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TABLE 2. Proliferation responses of PBMC from healthy individuals to gp43 and the eight gp43 peptides selected by a TEPITOPE algorithma
Control
subject
no.
SI value for indicated concn (M) of peptide: SI for control
gp43
(45–59)
gp43
(94–108)
gp43
(106–120)
gp43
(283–295)
gp43
(180–194)
gp43
(183–197)
gp43
(179–199)
gp43
(181–195) gp43
(1 g) PHA
0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10 0.1 1 10
02 - - - - - - - - - - - - - - - - - - - - - - - - - 232.1
05 - - - - - - - - - - - - - - - - - - - - - - - - - 234.1
06 - - - - - - - - - - - - - - - - - - - - - - - - - 439.2
07 - - - - - - - - - - - - - - - - - - - - - - - - - 353.2
09 - - - - - - - - - - - - - - - - - - - - - - - - - 545.3
12 - - - - - - - - - - - - - - - - - - - - - - - - - 216.4
04 - - - - - - - - - - - - - - - - - - - - - - - - 2.0 160.0
13 - - - - - - - - - - - - - - - - - - - - - - - - 2.9 265.9
14 - - - - - - - - - - - - - - - - - - - - - - - - 4.5 403.9
15 - - - - - - - - - - - - - - - - - - - - - - - - 2.5 216.0
16 - - - - - - - - - - - - - - - - - - - - - - - - 4.3 47.9
10 - - - - - - - - - - - - - - - - - - - - - 2.2 - - 4.4 189.1
01 - - - - - - - - - 2.4 - - - - - - - - - 2.0 - - - - 4.1 233.1
a PBMC (105 cells/well) were stimulated by peptides at concentrations of 0.1, 1.0, and 10.0 M as described. Only positive stimulation index (SI) values of 2 are
shown. Dashes (-) correspond to SI values of 2. Positive control, phytohemagglutinin (PHA).
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